Achieving inactive disease in enthesitis-related arthritis with secukinumab following TNF-inhibitor failure.

Autor: Papailiou S; 2nd Department of Pediatrics, 'Panagiotis and Aglaia Kiriakou' Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece., Onoufriou M; Department of Pediatrics, 'Archbishop Makarios III' Children's Hospital, Leucosia, Cyprus., Mentesidou L; 1st Department of Pediatrics, 'Panagiotis and Aglaia Kiriakou' Children's Hospital, Athens, Greece., Syggelou A; 2nd Department of Pediatrics, 'Panagiotis and Aglaia Kiriakou' Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece., Tsolia MN; 2nd Department of Pediatrics, 'Panagiotis and Aglaia Kiriakou' Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece., Maritsi DN; 2nd Department of Pediatrics, 'Panagiotis and Aglaia Kiriakou' Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece.; Department of Pediatrics, 'Archbishop Makarios III' Children's Hospital, Leucosia, Cyprus.
Jazyk: angličtina
Zdroj: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 Nov 01; Vol. 63 (11), pp. e297-e298.
DOI: 10.1093/rheumatology/kead656
Databáze: MEDLINE